KRMD (KORU Medical Systems, Inc. Common Stock (DE)) Stock Analysis - SEC Filings

KORU Medical Systems, Inc. Common Stock (DE) (KRMD) is a publicly traded Healthcare sector company. As of May 21, 2026, KRMD trades at $4.00 with a market cap of $175.92M and a P/E ratio of -80.40. KRMD moved +1.14% today. Year to date, KRMD is -28.19%; over the trailing twelve months it is +35.59%. Its 52-week range spans $1.86 to $6.61. Analyst consensus is strong buy with an average price target of $6.75. Rallies surfaces KRMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find KRMD SEC filings?

Rallies organizes KRMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

KRMD Key Metrics

Key financial metrics for KRMD
MetricValue
Price$4.00
Market Cap$175.92M
P/E Ratio-80.40
EPS$-0.05
Dividend Yield0.00%
52-Week High$6.61
52-Week Low$1.86
Volume410
Avg Volume0
Revenue (TTM)$43.26M
Net Income$-2.28M
Gross Margin61.93%

Latest KRMD News

Recent KRMD Insider Trades

  • Schiller Eric bought 5.00K (~$19.56K) on May 18, 2026.
  • Tharby Linda M bought 1.19K (~$4.67K) on May 15, 2026.
  • Tharby Linda M bought 1.19K (~$1.42M) on May 15, 2026.

KRMD Analyst Consensus

5 analysts cover KRMD: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.75.

Common questions about KRMD

Where can I find KRMD SEC filings?
Rallies organizes KRMD SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show KRMD 10-K and 10-Q filings?
Rallies organizes KRMD SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is KRMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for KRMD. It does not provide personalized investment advice.
KRMD

KRMD